Abstract

It has been known that EGF-like factor secreted from LH-stimulated granuloma cells acts on granulosa cells and cumulus cells to induce ovulation process. Granulosa cells are changed the morphology with differentiating cell functions to produce progesterone. Cumulus cells are detached to make a space between the cells to accumulate hyaluronan rich matrix. LH also changes extracellular matrix (ECM) components including fibronectin in the follicular walls and granulosa cell layers. EGF like factor and fibronectin synergistically play important roles in numerous cell functions, especially cancer cell migration, estimating that fibronectin would impact on granulosa cells and cumulus cells. To clear this hypothesis, the localizations of fibronectin and its receptor integrin were observed by immunofluorescence technique. The functions were monitored by the detection of downstream signaling pathway, focal adhesion kinase (FAK). The pharmacological approach in both in vivo and in vitro were used for analyzing the physiological roles of FAK during ovulation process. The immunofluorescence staining revealed that fibronectin and integrin were observed in granulosa cells, cumulus cells and the space between cumulus cells and oocyte at 4 and 8 h after hCG injection. Concomitantly with the changes of fibronectin-integrin localization, FAK was phosphorylated in periovulatory follicles. The injection of FAK inhibitor suppressed not only ovulation but also luteinization of granulosa cells and cumulus expansion. In cultured-granulosa cells, fibronectin-integrin synergistically activated FAK with amphiregulin (AREG). Such cooperative stimulations induced a morphological change in granulosa cells, which resulted in the maximum level of progesterone production via the induction of Hsd3b. When cumulus-oocyte complexes (COCs) were cultured with AREG in the presence of serum, the maximum level of cumulus expansion was observed. The AREG-induced cumulus expansion was also suppressed by FAK inhibitor. Thus, it is concluded that fibronectin and AREG synergistically activate FAK not only in granulosa cells and cumulus cells to induce successful ovulation process.

Highlights

  • Luteinizing hormone (LH) is transiently secreted from pituitary glands and acts on its receptor expressed on granulosa cells to induce ovulation process [1]

  • To clarify the roles of focal adhesion kinase (FAK) activated by both fibronectin and epidermal growth factor (EGF)-like factor in granulosa cells during ovulation, FAK inhibitor Y15 was co-injected with human chorionic gonadotropin (hCG), and we examined its Fibronectin-integrin pathway during ovulation process female mice treated with Equine chorionic gonadotropin (eCG) followed by hCG stimulation; Y15: mice co-injected with hCG and Y15 (30 mg/kg) at 48 h after eCG injection. (D): Expression of genes involved in progesterone production and hyaluronic acid synthesis in the ovary of mice treated with hCG and Y15 (30 mg/kg)

  • The phosphorylation of FAK was dependent on EGFR ligand AREG and fibronectin in cultured granulosa cells

Read more

Summary

Introduction

Luteinizing hormone (LH) is transiently secreted from pituitary glands and acts on its receptor expressed on granulosa cells to induce ovulation process [1]. The EGF-like factor-EGFR pathway increases the enzymatic activity of calpain 2 via both Ca2+ induction and ERK1/2 activation in cumulus cells during ovulation process [6]. Cofilin is known to be regulated by an EGFR-dependent pathway in fibroblasts [10], indicating that the EGF-like factor-EGFR pathway induces differentiation of granulosa cells and cumulus cells during ovulation process via both changes in gene expression patterns and morphological changes of the cells. The latter mechanisms that change the shape of both granulosa cells and cumulus cells have been unclear

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.